Cargando…

Prolonged-Release Buprenorphine Therapy in Opioid Use Disorder Can Address Stigma and Improve Patient Quality of Life

Treatment for opioid use disorder (OUD) including opioid agonist therapy (OAT) is effective. Medication with the oral administration of methadone and buprenorphine has well-known limitations (establishing consistent optimal dosing levels, misuse, diversion, and accidental exposure). Treatment may re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somaini, Lorenzo, Vecchio, Sarah, Corte, Camilla, Coppola, Carmen, Mahony, Aisling, Pitts, Alexandra, Cutuli, Manuela, Orso, Rosetta, Littlewood, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568308/ https://www.ncbi.nlm.nih.gov/pubmed/34754672 http://dx.doi.org/10.7759/cureus.18513

Ejemplares similares

Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review
por: Spreen, Lauren A., et al.
Publicado: (2022)

Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine
por: D'Agnone, Oscar
Publicado: (2019)

COVID19 pandemic and people with opioid use disorder: innovation to reduce risk
por: Vecchio, Sarah, et al.
Publicado: (2020)

Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine
por: Gilman, Mark, et al.
Publicado: (2018)

Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine
por: Parsons, Graham, et al.
Publicado: (2020)

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis
por: Wright, Nat, et al.
Publicado: (2020)

Increased Treatment Engagement and Adherence: Flexible Management with Prolonged-Release Buprenorphine in Treatment of Opioid Dependence
por: Hard, Bernadette
Publicado: (2021)

Systematic Review of the Safety and Tolerability of Injectable Prolonged-Release Buprenorphine (Buvidal) in Adults With Opioid Dependence
por: Williams, Laura, et al.
Publicado: (2023)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
por: Phillips-Jackson, Helen, et al.
Publicado: (2020)

Health-related quality of life and stigma in opioid dependence: Comparison between buprenorphine users and non-users
por: Garg, Rohit, et al.
Publicado: (2023)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Treatment of opioid dependence with buprenorphine: current update
por: Soyka, Michael
Publicado: (2017)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy
por: Gupta, Ramji
Publicado: (2015)

Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
por: Neale, Joanne, et al.
Publicado: (2019)

Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study
por: Hard, Bernadette, et al.
Publicado: (2023)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Addressing Stigma is Not Enough
por: Amon, Joseph J., et al.
Publicado: (2022)

The Power of Technology Addressing Anxiety for a Better Mental Health
por: Minier, J.-C.
Publicado: (2022)

Pattern of buprenorphine abuse among opioid abusers in Nepal
por: Aich, Tapas Kumar, et al.
Publicado: (2010)

Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Opioid-Dependents
por: Ziaaddini, Hassan, et al.
Publicado: (2012)

Sleep problems in opioid dependent patients maintained on buprenorphine
por: Tripathi, R., et al.
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies
por: Ali, Ali Mohamed, et al.
Publicado: (2023)

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
por: Li, Hanbin, et al.
Publicado: (2019)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
por: Kranzler, Henry R, et al.
Publicado: (2020)

Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults
por: Guerriero, Fabio
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_40vpbv5tfhl8vpgf5416mduoq2